May 22, 2013 by Dave WilliamsonWall Street Loves this New Immunotherapy Cancer DrugBristol-Myers Squibb gets a huge upgrade on the back of cancer-fighting immunotherapy drug nivolumab.
May 22, 2013 by Dave WilliamsonA New Cancer-Killing VirusOncolytics announces successful tests for cancer drug Reolysin.
May 21, 2013 by Dave WilliamsonAnother Multiple Sclerosis Winner for BiogenBiogen submits Plegridy for FDA approval.
May 21, 2013 by Dave Williamson1 Big Pharma Phase 3 FailurePfizer's non-Hodgkin's lymphoma drug saw its phase 3 trial halted for lack of efficacy.
May 21, 2013 by Dave WilliamsonWhen Savvy Dealmaking Borders on Reckless SpendingIs Elan deftly making deals or blowing its newfound cash hoard?
May 20, 2013 by Dave WilliamsonFDA Green Light = Surprise Share SurgeDid this FDA decision really justify a big stock pop?
May 20, 2013 by Dave WilliamsonEveryone Wins From This AcquisitionActavis buys Warner Chilcott rather than get acquired itself and investors win.
May 19, 2013 by Dave WilliamsonMultiple Sclerosis and Hemophilia: This Biotech's Just Getting StartedBiogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.
May 19, 2013 by Dave WilliamsonThe Implications of Monsanto's Supreme Court Win The biotech agricultural giant racks up yet another patent triumph.
May 19, 2013 by Dave WilliamsonCloning: A Stem Cell Revolution?Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?
May 16, 2013 by Dave WilliamsonCancer Drug Drama Rocks 2 Biotech StocksASCO abstracts lead to one big pop and one big drop
May 16, 2013 by Dave WilliamsonPresentation Pandemonium = 30% PopWhy shares of Aegerion soared more than 30% today.
May 15, 2013 by Dave WilliamsonWhy Bristol-Myers Is SoaringThe speculation centers around Bristol-Myers' cancer trial results.
May 13, 2013 by Dave WilliamsonFDA Prioritizes New Hepatitis C DrugIs Johnson & Johnson's simeprevir destined to be the first next-gen hepatitis-C drug.
May 13, 2013 by Dave WilliamsonThe Danger of Chasing This IPO's ProfitsThe largest contract research organization is back on the market
May 12, 2013 by Dave WilliamsonCuring Back Pain and Preventing DiabetesTwo EU studies have some really interesting studies with far-reaching impacts.
May 12, 2013 by Dave WilliamsonDo Micro-Cracks Equal Major Problems?Intuitive Surgical warns of a potentially defective module.
May 12, 2013 by Dave WilliamsonThe Real Impact of Irrational Hospital PricingThe CMS releases hospital pricing data for the first time, and outrage ensues.
May 12, 2013 by Dave WilliamsonHow the Patent Cliff Is Shrinking U.S. SpendingIs the patent cliff a government spending cure?
May 12, 2013 by Dave WilliamsonNo Relief in Sight for Pain Therapeutics Investors Why shares of Pain Therapeutics were slashed in half.
